This Solicitation opportunity from Department Of Defense was posted on April 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
LAMIVUDINE AND ZIDO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to the procurement of Lamivudine and Zidovudine tablets, specifically in 150 mg and 300 mg strengths packaged in bottles containing 60 tablets each. The packaging must meet the Defense Logistics Agency (DLA) requirements, ensuring that each unit is securely sealed in a container that protects its contents from damage and breakage during shipment. Units are to be packed in commercial-grade shipping containers suitable for transport, including export containers when necessary, and marked according to Medical Marking Standard No. 1. These standards supersede prior military specifications to ensure compliance and protect the integrity of the product during shipment and delivery. The medication is regulated by the FDA, and buyers are instructed to refer any contract inquiries to designated product specialists for confirmation. The contract specifies a shelf life of 24 months (non-extendable) under Type I (Code M), with inspection and acceptance to occur at the destination within 20 days of delivery notice. The contract references specific manufacturer details, including ViiV Healthcare Company and XLCARE Pharmaceuticals Inc., with their respective part numbers and National Drug Codes. All packaging, marking, inspection, and quality standards align with the DLA Master List of Technical and Quality Requirements. The purchase is for one bottle (unit of issue) and is to be delivered FOB destination with no quantity variance allowed. The solicitation is managed by the Department of Defense's Medical Supply Chain Pharmacy FSA office, with Fort Carson identified as the place of performance and Morgan Kelly as the primary point of contact.
General Info
Agency
NAICS
Place of Performance
BLDG 7465 BAD TOELZ RD, FORT CARSON, CO, 80913-4093, USASet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
LAMIVUDINE AND ZIDOVUDINE TABLETS<(>,<)>
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
150 MG AND 300 MG RESPECTIVELY, 60'S
U/I "BT" (60'S)
INCLUDE R2744 OBJECT TEXT ID ST
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information,
SPE2DP-26-T-2860
SECTION B
manufacturer name, manufacturer part number, and item description. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
VIIV HEALTHCARE COMPANY 661F7 P/N NDC49702-0202-18 XLCARE PHARMACEUTICALS INC 86SL9 P/N NDC72865-0144-60
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016288020 0001 BT 1.000
NSN/MATERIAL:6505014629945
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-462-9945 Quantity: 1 BT Purchase Request: 7016288020QTY: 1 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS